Literature DB >> 12152933

Kidney disease in Native Americans.

Andrew S Narva.   

Abstract

Over the past few decades, the disease burden among American Indians and Alaska Natives (Al/AN) has shifted from acute infectious diseases to chronic illnesses, particularly type 2 diabetes and its complications. AI/ANs experience high rates of end-stage renal disease (ESRD), mainly driven by the increase in diabetes. The prevalence of ESRD is 3.5 times greater than that in white Americans. The burden of ESRD has become a community-wide problem among many tribes, and significant efforts have gone into establishing dialysis services on reservations. Reservation-based dialysis services have improved the access of patients to renal replacement therapy, but enormous barriers to improving care remain. These include: the rural and frequently isolated locations that make traveling to facilities difficult owing to distance and road conditions; high rates of poverty; difficulty in recruiting and retaining staff in outlying areas; language and cultural differences; and the high numbers of patients with diabetes and extra-renal diabetic complications. Disparities exist in access to kidney transplantation, with AI/ANs waiting longer for organs than their white counterparts. However, once transplanted, they have comparable survival rates to white Americans. An aggressive approach to intervention, which includes prevention and optimal therapy, is required to slow the growth of ESRD amongst AI/ANs.

Entities:  

Mesh:

Year:  2002        PMID: 12152933      PMCID: PMC2594281     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  6 in total

1.  Mesangial proliferative glomerulonephritis in southwestern American Indians.

Authors:  W E Hoy; S M Smith; M D Hughson; D M Megill
Journal:  Transplant Proc       Date:  1989-12       Impact factor: 1.066

2.  A population-based, cross-sectional survey of the Zuni Pueblo: a collaborative approach to an epidemic of kidney disease.

Authors:  Christine A Stidley; Vallabh O Shah; Andrew S Narva; Diane Dalton; Jean W MacCluer; Arlene Bobelu; Marina Scavini; Thomas K Welty; Philip G Zager
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 3.  Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective.

Authors:  A Fagot-Campagna; D J Pettitt; M M Engelgau; N R Burrows; L S Geiss; R Valdez; G L Beckles; J Saaddine; E W Gregg; D F Williamson; K M Narayan
Journal:  J Pediatr       Date:  2000-05       Impact factor: 4.406

4.  Access of Native Americans to renal transplantation in Arizona and New Mexico.

Authors:  A Narva; S Stiles; S Karp; A Turak
Journal:  Blood Purif       Date:  1996       Impact factor: 2.614

5.  Prevalence of diabetes among Native Americans and Alaska Natives, 1990-1997: an increasing burden.

Authors:  N R Burrows; L S Geiss; M M Engelgau; K J Acton
Journal:  Diabetes Care       Date:  2000-12       Impact factor: 19.112

6.  Regional differences in albuminuria among American Indians: an epidemic of renal disease.

Authors:  D C Robbins; W C Knowler; E T Lee; J Yeh; O T Go; T Welty; R Fabsitz; B V Howard
Journal:  Kidney Int       Date:  1996-02       Impact factor: 10.612

  6 in total
  5 in total

1.  Transplant center assessment of the inequity in the kidney transplant process and outcomes for the Indigenous American patients.

Authors:  Mira T Keddis; Amit Sharma; Muneeb Ilyas; Nan Zhang; Hasan Khamash; Scott J Leischow; Raymond L Heilman
Journal:  PLoS One       Date:  2018-11-21       Impact factor: 3.240

2.  Native American patients' perception and attitude about kidney transplant: a qualitative assessment of patients presenting for kidney transplant evaluation.

Authors:  Mira Keddis; Dawn Finnie; Wonsun Sunny Kim
Journal:  BMJ Open       Date:  2019-01-28       Impact factor: 2.692

3.  Patient and allograft outcomes after kidney transplant for the Indigenous patients in the United States.

Authors:  Regan Seipp; Nan Zhang; Sumi Sukumaran Nair; Hasan Khamash; Amit Sharma; Scott Leischow; Raymond Heilman; Mira T Keddis
Journal:  PLoS One       Date:  2021-02-03       Impact factor: 3.240

4.  Does losartan prevent progression of early diabetic nephropathy in American Indians with type 2 diabetes?

Authors:  Susanne B Nicholas; Sudha K Iyengar
Journal:  Diabetes       Date:  2013-09       Impact factor: 9.461

5.  Epidemiology of Glomerular Disease in Southern Arizona: Review of 10-Year Renal Biopsy Data.

Authors:  Sangeetha Murugapandian; Iyad Mansour; Mohammad Hudeeb; Khaled Hamed; Emad Hammode; Babitha Bijin; Sepehr Daheshpour; Bijin Thajudeen; Pradeep Kadambi
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.